Rise in number of emergency surgeries to propel market growth for Injectable Anesthesia
Many drugs are administered through injection for maintenance and induction of anesthesia. Anesthesia is administered in the body by combination of injectable drugs with inhalation agents for long span of time or, exclusively with injectable anesthesia drugs for shorter span of time. Injectable anesthesia helps to numb the particular area of the body by dismissing or blocking any kind of painful signal from being communicated to the brain. Injectable anesthesia are highly preferred for surgical procedures, among which the most common applications are, during labor, dental procedures and different other operative procedures. The most standard injectable anesthesia drug to which most other injectable anesthesia drugs are compared in thiopental. A few anesthesia adjuvant drugs are considered to be vital to contemporary discussion of injectable anesthesia re alpha-2 adrenergic and benzodiazepine agents. Regional injectable anesthesia is highly performed to provide more comfort during and after any operative procedure.
Increase in number of dental procedures, and other surgical procedures that require anesthesia is expected to fuel the market growth for injectable anesthesia. Rapid rise in aging population, increase in number of local manufacturers for injectable anesthesia drugs and increasing prevalence of several respiratory system-related and cardiovascular diseases is also projected to boost the demand for injectable anesthesia. There is a consistent growth in number of emergency surgeries performed every year, worldwide. This is further expected to contribute to the growth of the injectable anesthesia market during the forecast years. However, there are certain side-effects related to injectable anesthesia drugs, such as, elevation in heart rate and blood pressure, respiratory depression, amnesia, and different types of hallucinations. These side effects, low compliance rates of injectable anesthesia drugs, mortality rate related with the overuse of injectable anesthesia and various other regulatory issues with injectable anesthesia drugs is expected to obstruct market growth for injectable anesthesia during the forecast period.
Tentatively, Injectable Anesthesia Market has been segmented on the basis of product type, usability, application, end user, and geography.
Based on drug class, Global Injectable Anesthesia market is segmented as below:
Based on application, Global Injectable Anesthesia market is segmented as below:
Based on end user, Global Injectable Anesthesia market is segmented as below:
Global Injectable Anesthesia market has witnessed a moderate growth owing it to various potential hazards associated to Injectable Anesthesia. Certain safety updates and regulations are formulated by the government and different health associations which is expected to boost the market growth for Injectable Anesthesia over the forecast period. Injectable Anesthesia is highly preferred for dental procedures. By the application, dental Injectable Anesthesia devices are expected to grow at a healthy rate owing it to the increase in incidence of dental surgeries performed annually. Ambulatory surgical centers are expected to fuel the market for injectable anesthesia, owing it to the increase in accident rates resulting into emergency surgeries performed worldwide. However, mortality rates associated with overuse of injectable anesthesia drugs could hinder the market growth for injectable anesthesia.
The US Injectable Anesthesia market is projected to witness a robust growth in the North American market for injectable anesthesia owing it to the increase in number of surgical procedures and huge number of manufacturer presence for injectable anesthesia drugs in the region. Asia-Pacific’s injectable anesthesia market and Europe’s market for injectable anesthesia drugs is also expected to grow at a significant rate during the forecast period because of the increase in prevalence for respiratory system-related and cardiovascular disorders. Increase in healthcare expenditure and improved healthcare infrastructure in also expected to boost demand for injectable anesthesia in the region. MEA Injectable Anesthesia market is expected to witness decent growth owing it to less per capita income resulting in less affordability and poor healthcare infrastructure resulting in less availability of injectable anesthesia during surgical procedures.
Some of the market participants in the Global Injectable Anesthesia market identified across the value chain include Abbott, Baxter, F. Hoffmann-La Roche, AstraZeneca, B. Braun Melsungen AG, AbbVie Inc, Fresenius SE & Co. KgaA, Eisai Co., Ltd., Boehringer Ingelheim International GmbH, Hikma Pharmaceuticals PLC, Teva Pharmaceuticals, Novartis AG, Sagent Pharmaceutical, Inc., Nichi-Iko Pharmaceutical Co., Ltd., Mylan N.V., and Par Pharmaceutical.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The report covers exhaustive analysis on:
Regional analysis includes: